SG11201807185UA - Modified hyaluronic acid, method for making same and uses thereof - Google Patents
Modified hyaluronic acid, method for making same and uses thereofInfo
- Publication number
- SG11201807185UA SG11201807185UA SG11201807185UA SG11201807185UA SG11201807185UA SG 11201807185U A SG11201807185U A SG 11201807185UA SG 11201807185U A SG11201807185U A SG 11201807185UA SG 11201807185U A SG11201807185U A SG 11201807185UA SG 11201807185U A SG11201807185U A SG 11201807185UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- modified
- hyaluronic acid
- pct
- making same
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 8
- 229920002674 hyaluronan Polymers 0.000 abstract 3
- 229960003160 hyaluronic acid Drugs 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000002500 effect on skin Effects 0.000 abstract 2
- 239000000945 filler Substances 0.000 abstract 2
- 239000000017 hydrogel Substances 0.000 abstract 2
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 abstract 1
- 230000003190 augmentative effect Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16000715 | 2016-03-24 | ||
| PCT/EP2017/056701 WO2017162676A1 (fr) | 2016-03-24 | 2017-03-21 | Acide hyaluronique modifié, procédé pour le fabriquer et ses utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201807185UA true SG11201807185UA (en) | 2018-09-27 |
Family
ID=55642206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201807185UA SG11201807185UA (en) | 2016-03-24 | 2017-03-21 | Modified hyaluronic acid, method for making same and uses thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10640578B2 (fr) |
| EP (1) | EP3433284A1 (fr) |
| JP (1) | JP6946323B2 (fr) |
| KR (1) | KR102316644B1 (fr) |
| CN (1) | CN108779185B (fr) |
| AR (1) | AR107967A1 (fr) |
| AU (1) | AU2017237457B2 (fr) |
| BR (1) | BR112018068559B8 (fr) |
| CA (1) | CA3016272A1 (fr) |
| IL (1) | IL261574B2 (fr) |
| MX (1) | MX2018011053A (fr) |
| RU (1) | RU2733444C2 (fr) |
| SG (1) | SG11201807185UA (fr) |
| TW (1) | TWI727014B (fr) |
| WO (1) | WO2017162676A1 (fr) |
| ZA (1) | ZA201805424B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3684379A4 (fr) * | 2017-09-19 | 2021-06-09 | The Hong Kong University Of Science And Technology | Matériau biocompatible et procédés de fabrication et d'utilisation de celui-ci |
| US20210008249A1 (en) | 2018-03-12 | 2021-01-14 | Merz Pharma Gmbh & Co. Kgaa | Porous biomaterials for tissue regeneration |
| MX2021007083A (es) * | 2018-12-19 | 2021-10-13 | Merz Pharma Gmbh & Co Kgaa | Acido hialuronico modificado con aldehido, metodo de preparacion del mismo y sus aplicaciones. |
| AU2019401735B2 (en) * | 2018-12-20 | 2022-08-25 | Lg Chem, Ltd. | Filler having excellent filler properties comprising hyaluronic acid hydrogel |
| EP4038105B1 (fr) * | 2019-10-01 | 2024-01-10 | Biopolimeri S.r.l. | Éther polyglycidylique de polyglycérol hyperramifié et son utilisation en tant qu'agent de réticulation de polysaccharides |
| FR3111903B1 (fr) | 2020-06-24 | 2022-12-02 | Lab Vivacy | Procede d’incorporation de composes organiques en solution au sein d’un hydrogel |
| FR3113522A1 (fr) | 2020-08-20 | 2022-02-25 | Laboratoires Vivacy | procédé d’évaluation des caractéristiques rhéologiques d’un gel |
| TW202317214A (zh) | 2021-06-23 | 2023-05-01 | 德商莫茲製藥有限兩合公司 | 以絲蛋白交聯多醣及所得材料之用途 |
| WO2023135135A1 (fr) | 2022-01-11 | 2023-07-20 | Gpq S.R.L. | Nouveaux dérivés d'acides hyaluroniques en tant que combleurs innovants |
| ES2947097A1 (es) * | 2022-02-01 | 2023-08-01 | Martinez Miguel Angel Gomariz | Metodo cosmetico de rejuvenecimiento de la piel |
| FR3135399A1 (fr) | 2022-03-30 | 2023-11-17 | Laboratoires Vivacy | émulsion comprenant un hydrogel et de la graisse ou un dérivé de graisse |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61150844A (ja) | 1984-12-21 | 1986-07-09 | Meidensha Electric Mfg Co Ltd | 電鉄用回生インパ−タの制御方法 |
| TWI251596B (en) * | 2002-12-31 | 2006-03-21 | Ind Tech Res Inst | Method for producing a double-crosslinked hyaluronate material |
| FR2865737B1 (fr) | 2004-02-03 | 2006-03-31 | Anteis Sa | Gel reticule biocompatible |
| WO2006025556A1 (fr) * | 2004-08-31 | 2006-03-09 | Showa Denko K.K. | Matière de phase stationnaire modifiée en surface pour la chromatographie en phase liquide et procédé de production de celle-ci |
| JP5022618B2 (ja) * | 2005-04-05 | 2012-09-12 | 株式会社 資生堂 | ヒドロキシアルキル化ヒアルロン酸 |
| KR100849185B1 (ko) * | 2006-01-19 | 2008-07-30 | 서울산업대학교 산학협력단 | 키토산 또는 히알루론산-폴리에틸렌옥사이드 및키토산-히알루론산-폴리에틸렌옥사이드를 기저로 하는하이드로젤과 이의 제조방법 |
| WO2008034176A1 (fr) * | 2006-09-19 | 2008-03-27 | Ultraceuticals R & D Pty Ltd | Gels de polysaccharides réticulés |
| FR2909560B1 (fr) | 2006-12-06 | 2012-12-28 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
| CN101502677B (zh) * | 2008-02-04 | 2013-06-26 | 凌沛学 | 一种注射用交联透明质酸钠凝胶及其制备方法 |
| CN101538377A (zh) * | 2008-03-20 | 2009-09-23 | 上海昊海生物科技有限公司 | 一种交联透明质酸凝胶及其制备方法 |
| US8450475B2 (en) * | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| US9371402B2 (en) * | 2009-04-09 | 2016-06-21 | Scivision Biotech Inc. | Method for producing cross-linked hyaluronic acid |
| US20100261893A1 (en) * | 2009-04-09 | 2010-10-14 | Scivision Biotech Inc. | Method for producing cross-linked hyaluronic acid |
| FR2945949B1 (fr) * | 2009-05-26 | 2011-05-13 | Anteis Sa | Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme. |
| US8790702B2 (en) * | 2009-07-30 | 2014-07-29 | Carbylan Therapeutics, Inc. | Modified hyaluronic acid polymer compositions and related methods |
| JP4845071B2 (ja) * | 2010-02-19 | 2011-12-28 | キユーピー株式会社 | 修飾ヒアルロン酸および／またはその塩、ならびにその製造方法およびこれを含む化粧料 |
| US20130196944A1 (en) * | 2010-08-19 | 2013-08-01 | Merz Pharma Gmbh & Co. Kgaa | Filler composition comprising beta-glucans |
| RU2496793C1 (ru) * | 2012-06-14 | 2013-10-27 | Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук | Способ получения 2,3-дигидроксипропилхитозана |
| AU2013276844B2 (en) | 2012-06-15 | 2017-09-28 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing a composition based on hyaluronic acid |
| US20140275340A1 (en) | 2013-03-15 | 2014-09-18 | Lake Region Manufacturing, Inc. d/b/a Lake Region Medical | Modified hyaluronate hydrophilic compositions, coatings and methods |
| FR3006689A1 (fr) * | 2013-06-11 | 2014-12-12 | Benedicte Vincente Tauzin | Procede de reticulation de l'acide hyaluronique; procede de preparation d'un hydrogel injectable; hydrogel obtenu; utilisation de l'hydroget obtenu |
| AR099900A1 (es) * | 2014-04-01 | 2016-08-24 | Merz Pharma Gmbh & Co Kgaa | Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso |
| CN104194008B (zh) * | 2014-08-08 | 2017-09-15 | 陕西佰傲再生医学有限公司 | 一种交联透明质酸凝胶微粒及其制备方法 |
-
2017
- 2017-03-10 TW TW106107945A patent/TWI727014B/zh active
- 2017-03-21 AU AU2017237457A patent/AU2017237457B2/en active Active
- 2017-03-21 BR BR112018068559A patent/BR112018068559B8/pt active IP Right Grant
- 2017-03-21 RU RU2018129659A patent/RU2733444C2/ru active
- 2017-03-21 JP JP2018548401A patent/JP6946323B2/ja active Active
- 2017-03-21 CN CN201780018177.6A patent/CN108779185B/zh active Active
- 2017-03-21 SG SG11201807185UA patent/SG11201807185UA/en unknown
- 2017-03-21 MX MX2018011053A patent/MX2018011053A/es unknown
- 2017-03-21 WO PCT/EP2017/056701 patent/WO2017162676A1/fr active Application Filing
- 2017-03-21 US US16/087,248 patent/US10640578B2/en active Active
- 2017-03-21 CA CA3016272A patent/CA3016272A1/fr active Pending
- 2017-03-21 IL IL261574A patent/IL261574B2/en unknown
- 2017-03-21 EP EP17710992.3A patent/EP3433284A1/fr active Pending
- 2017-03-21 KR KR1020187026925A patent/KR102316644B1/ko active IP Right Grant
- 2017-03-23 AR ARP170100730A patent/AR107967A1/es active IP Right Grant
-
2018
- 2018-08-14 ZA ZA2018/05424A patent/ZA201805424B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017162676A1 (fr) | 2017-09-28 |
| IL261574B2 (en) | 2024-03-01 |
| IL261574B1 (en) | 2023-11-01 |
| KR102316644B1 (ko) | 2021-10-26 |
| CA3016272A1 (fr) | 2017-09-28 |
| JP2019509385A (ja) | 2019-04-04 |
| AU2017237457A1 (en) | 2018-09-06 |
| IL261574A (en) | 2018-10-31 |
| RU2018129659A3 (fr) | 2020-05-27 |
| TWI727014B (zh) | 2021-05-11 |
| JP6946323B2 (ja) | 2021-10-06 |
| RU2733444C2 (ru) | 2020-10-01 |
| US20190100605A1 (en) | 2019-04-04 |
| AU2017237457B2 (en) | 2021-04-08 |
| CN108779185B (zh) | 2021-09-17 |
| BR112018068559B1 (pt) | 2022-09-20 |
| EP3433284A1 (fr) | 2019-01-30 |
| US10640578B2 (en) | 2020-05-05 |
| BR112018068559A2 (pt) | 2019-04-16 |
| KR20180127983A (ko) | 2018-11-30 |
| TW201805008A (zh) | 2018-02-16 |
| AR107967A1 (es) | 2018-07-04 |
| BR112018068559B8 (pt) | 2022-11-01 |
| CN108779185A (zh) | 2018-11-09 |
| RU2018129659A (ru) | 2020-04-24 |
| MX2018011053A (es) | 2019-03-28 |
| ZA201805424B (en) | 2019-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201807185UA (en) | Modified hyaluronic acid, method for making same and uses thereof | |
| SG11201906431UA (en) | Method for the treatment of thromboembolism | |
| SG11201408261UA (en) | Syringe | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201407837WA (en) | Beta-hairpin peptidomimetics | |
| SG11201407961WA (en) | Risperidone or paliperidone implant formulation | |
| SG11201407340YA (en) | Treatment of myelosuppression | |
| SG11201407971QA (en) | Paliperidone implant formulation | |
| SG11201407200TA (en) | Liquid formulation | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201808710UA (en) | Novel immunogenic cd1d binding peptides | |
| SG11201805311XA (en) | Method of treating a mammal, including human, against cancer using methionine and asparagine depletion | |
| SG11201907441WA (en) | Improvements in or relating to organic compounds | |
| SG11201408509PA (en) | Racecadotril lipid compositions | |
| SG11201408709TA (en) | Therapeutic support for being worn by a subject | |
| SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| SG11201900043TA (en) | Antibody formulations | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
| SG11202000141WA (en) | Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof | |
| SG11201909906QA (en) | Organic compounds | |
| SG11201811246RA (en) | Novel silybum marianum achene extract and uses thereof in dermatology and dermo-cosmetics | |
| SG11201408230VA (en) | Therapeutic formulation and methods of treatment | |
| SG11201903100TA (en) | Method of preparing peptides comprising a lipophilically modified lysine side chain | |
| SG11201809494VA (en) | Pharmaceutical composition comprising eteplirsen |